Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01817686 · ClinicalTrials.gov registry record · NA
Study of Default Options in Advance Directives
A NA study, sponsored by Corporal Michael J. Crescenz VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT01817686 is a NA study that has completed, run by Corporal Michael J. Crescenz VA Medical Center. The registered enrollment target is 62 participants.
The verdict
NCT01817686, a NA study, has completed, sponsored by Corporal Michael J. Crescenz VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
Default options represent the events or conditions that are set into place if no alternatives are actively chosen. The setting of default options has well-established effects on a broad range of human decisions, but its influence on patients' preferences for end-of-life care is only beginning to be understood. This is a 3-armed randomized clinical trial in Veterans at high risk for critical illness, assessing the impact of Advance Directive (AD) forms framed with different default options. The central goals are to assess how default options in ADs influence the end-of-life care choices made by patients at risk for critical care, and these patients' hospital and ICU utilization. The investigators hypothesize that setting defaults in real ADs will increase the proportion of Veterans selecting comfort-oriented plans of care, decrease selections of life-extending therapies such as mechanical ventilation and dialysis, and reduce the proportion of time during follow-up that Veterans spend in the hospital and/or ICU, without affecting patient satisfaction with end-of-life care planning.
Interventions
- OTHER Comfort Default AD forms
- OTHER Life Extension Default AD forms
- OTHER Standard Default AD forms
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01817686
The ClinicalTrials.gov registry entry for NCT01817686 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corporal Michael J. Crescenz VA Medical Center, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Comfort Default AD forms is the first listed.
NCT01817686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01817686 about?
NCT01817686 is a clinical study titled "Study of Default Options in Advance Directives". Default options represent the events or conditions that are set into place if no alternatives are actively chosen. The setting of default options has well-established effects on a broad range of human decisions, but its influence on patients' preferences for end-of-life care is only beginning to be ...
What is the current status of trial NCT01817686?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2013-03. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01817686?
The interventions under investigation include: Comfort Default AD forms (OTHER), Life Extension Default AD forms (OTHER), Standard Default AD forms (OTHER).
Who is sponsoring clinical trial NCT01817686?
This trial is sponsored by Corporal Michael J. Crescenz VA Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.